Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Giovanni Caforio, insider at Bristol-Myers Squibb
Giovanni Caforio Insider Alerts

Get notified the next time Giovanni Caforio buys or sells Bristol-Myers Squibb stock. Enter your email address below to get our daily insider buying and selling report.

Giovanni Caforio Insider Information

Giovanni Caforio, M.D. has been chief executive officer of Bristol Myers Squibb since May 2015 and has been serving on the company’s Board of Directors since June 2014. In May 2017, he assumed the role of chairman of the board.

As CEO, Giovanni has led the company’s focus on researching and developing transformational medicines, which includes a leading portfolio of immunotherapies that are fundamentally changing the way cancer is treated. Under his leadership, BMS is evolving its operating model, in order to increase speed and competitiveness. 

With a background as a physician, Giovanni has helped strengthen the company’s patient-focused culture -- one driven by innovation, speed, accountability and passion. As a leader, he is focused on the business value of a company culture that promotes and rewards diversity and inclusion. 

Prior to becoming CEO, Giovanni served as chief operating officer with responsibility for leading a fully integrated worldwide commercial organization and the companywide functions of Enterprise Services and Global Manufacturing & Supply. This was preceded by his work as the company’s chief commercial officer. 

Giovanni joined Bristol Myers Squibb in 2000 as vice president and general manager, Italy, in the Worldwide Medicines Group. He assumed added responsibility for Greece and Israel in 2001, and for South East Europe in 2003. In 2004, he was appointed senior vice president, European Marketing and Brand Commercialization. In 2007, he relocated to the US to assume the role of senior vice president, U.S. Oncology. In 2010, he was named senior vice president, Global Commercialization, Oncology and Immunology, before becoming president of the company’s U.S. organization in 2011. Prior to joining Bristol Myers Squibb, Giovanni spent 12 years with Abbott Laboratories in a number of leadership positions. 

Born and educated in Italy, Giovanni received his M.D. from the University of Rome. 

What is Giovanni Caforio's net worth?

The estimated net worth of Giovanni Caforio is at least $29.79 million as of March 22nd, 2021. Dr. Caforio owns 528,980 shares of Bristol-Myers Squibb stock worth more than $29,792,154 as of December 5th. This net worth evaluation does not reflect any other investments that Dr. Caforio may own. Learn More.

How do I contact Giovanni Caforio?

The corporate mailing address for Dr. Caforio and other Bristol-Myers Squibb executives is 430 E. 29TH STREET 14 FLOOR, NEW YORK NY, 10016. Bristol-Myers Squibb can also be reached via phone at (212) 546-4000 and via email at [email protected]

Has Giovanni Caforio been buying or selling shares of Bristol-Myers Squibb?

Giovanni Caforio has not been actively trading shares of Bristol-Myers Squibb during the last ninety days. Most recently, Giovanni Caforio sold 25,000 shares of the business's stock in a transaction on Monday, September 20th. The shares were sold at an average price of $60.64, for a transaction totalling $1,516,000.00.

Who are Bristol-Myers Squibb's active insiders?

Bristol-Myers Squibb's insider roster includes Giovanni Caforio (CEO), Adam Dubow (SVP), Joseph Eid (SVP), David Elkins (CFO), Louis Schmukler (EVP), and Rupert Vessey (EVP).

Are insiders buying or selling shares of Bristol-Myers Squibb?

During the last year, insiders at the biopharmaceutical company sold shares 9 times. They sold a total of 235,190 shares worth more than $14,998,351.25. The most recent insider tranaction occured on November, 24th when EVP Autenried Paul Von sold 17,353 shares worth more than $987,732.76. Insiders at Bristol-Myers Squibb own 0.1 % of the company.

Information on this page was last updated on 11/24/2021.

Giovanni Caforio Insider Trading History at Bristol-Myers Squibb

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/20/2021Sell25,000$60.64$1,516,000.00View SEC Filing Icon  
3/22/2021Sell25,000$62.20$1,555,000.00528,980View SEC Filing Icon  
8/31/2020Sell39,840$62.70$2,497,968.00445,584View SEC Filing Icon  
5/3/2016Sell34,594$71.31$2,466,898.14132,263View SEC Filing Icon  
2/17/2016Sell12,040$63.58$765,503.2076,738View SEC Filing Icon  
9/15/2014Sell26,691$49.87$1,331,080.17View SEC Filing Icon  
2/24/2014Sell41,563$54.44$2,262,689.7249,753View SEC Filing Icon  
5/31/2013Sell10,538$47.06$495,918.28View SEC Filing Icon  
5/23/2013Sell26,647$46.29$1,233,489.63View SEC Filing Icon  
2/27/2013Sell12,150$37.08$450,522.00View SEC Filing Icon  
See Full Table

Giovanni Caforio Buying and Selling Activity at Bristol-Myers Squibb

This chart shows Giovanni Caforio's buying and selling at Bristol-Myers Squibb by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bristol-Myers Squibb Company Overview

Bristol-Myers Squibb logo
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.
Read More

Today's Range

Now: $56.32
Low: $55.76
High: $56.69

50 Day Range

MA: $58.06
Low: $53.63
High: $60.62

2 Week Range

Now: $56.32
Low: $53.22
High: $69.75

Volume

18,445,586 shs

Average Volume

13,068,318 shs

Market Capitalization

$125.01 billion

P/E Ratio

N/A

Dividend Yield

3.54%

Beta

0.6
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!